Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Cancer Letters|August 23, 2005
Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell linesMaria-Magdalena Mocanu, Zsolt Fazekas, Miklós Petrás, et al.
Molecular Cancer Therapeutics|July 11, 2007
Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistanceMárk Barok, Jorma Isola, Zsuzsanna Pályi-Krekk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
Current perspectives on HER2 testing: a review of national testing guidelinesMichael Bilous, Mitch Dowsett, Wedad Hanna, et al.
Cancer Letters|December 22, 2007
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumorMárk Barok, Margit Balázs, Péter Nagy, et al.
BMC Clinical Pathology|January 26, 2011
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancerJuho Konsti, Mikael Lundin, Heikki Joensuu, et al.
BMC Cancer|September 12, 2012
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational studyAnna-Karin Falck, Pär-Ola Bendahl, Christian Ingvar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancerGreetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
The American Journal of Pathology|February 15, 2015
Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancersBoris Vassilev, Harri Sihto, Shiqian Li, et al.
BMC Clinical Pathology|February 20, 2008
The calcium-binding protein S100P in normal and malignant human tissuesSeppo Parkkila, Pei-Wen Pan, Aoife Ward, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technologyJutta E Laiho, Sami Oikarinen, Maarit Oikarinen, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Cancer Letters|August 23, 2005
Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell linesMaria-Magdalena Mocanu, Zsolt Fazekas, Miklós Petrás, et al.
Molecular Cancer Therapeutics|July 11, 2007
Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistanceMárk Barok, Jorma Isola, Zsuzsanna Pályi-Krekk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
Current perspectives on HER2 testing: a review of national testing guidelinesMichael Bilous, Mitch Dowsett, Wedad Hanna, et al.
Cancer Letters|December 22, 2007
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumorMárk Barok, Margit Balázs, Péter Nagy, et al.
BMC Clinical Pathology|January 26, 2011
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancerJuho Konsti, Mikael Lundin, Heikki Joensuu, et al.
BMC Cancer|September 12, 2012
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational studyAnna-Karin Falck, Pär-Ola Bendahl, Christian Ingvar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancerGreetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
The American Journal of Pathology|February 15, 2015
Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancersBoris Vassilev, Harri Sihto, Shiqian Li, et al.
BMC Clinical Pathology|February 20, 2008
The calcium-binding protein S100P in normal and malignant human tissuesSeppo Parkkila, Pei-Wen Pan, Aoife Ward, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technologyJutta E Laiho, Sami Oikarinen, Maarit Oikarinen, et al.
Pageof 15